Home › Canaccord Genuity Reaffirms Buy Rating for Regeneron Pharmaceuticals
 

Keywords :   


Canaccord Genuity Reaffirms Buy Rating for Regeneron Pharmaceuticals

2015-08-30 19:41:11| Biotech - Topix.net

's stock had its "buy" rating restated by research analysts at Canaccord Genuity in a research report issued on Wednesday, Market Beat Ratings reports. They presently have a $700.00 price target on the biopharmaceutical company's stock, up from their previous price target of $600.00.

Tags: buy rating pharmaceuticals reaffirms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.07Tropical Storm Beryl Public Advisory Number 36A
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
07.07Atlantic Tropical Weather Outlook
07.07Eastern North Pacific Tropical Weather Outlook
07.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Graphics
More »